Halozyme Therapeutics, Inc. (HALO)
64.50
-0.86
(-1.32%)
USD |
NASDAQ |
Apr 27, 16:00
64.91
+0.41
(+0.64%)
After-Hours: 20:00
Halozyme Therapeutics EPS Diluted (TTM) : 2.492 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 15.33 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 22.59 |
| Baxter International, Inc. | -1.679 |
| Glaukos Corp. | -3.271 |